The above results indicated that ZG16 could regulate the EMT in CRC cells, and GSEA analysis also showed a significant Wnt signaling enrichment in the ZG16-low-expression group of CRC patients (Figure 5A). The gene discussed is ZG16; the disease is colorectal carcinoma.